Schizophrenia susceptibility pathway neuregulin 1–ErbB4 suppresses Src upregulation of NMDA receptors
- 27 March 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 17 (4), 470-478
- https://doi.org/10.1038/nm.2315
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Neuroplasticity signaling pathways linked to the pathophysiology of schizophreniaNeuroscience & Biobehavioral Reviews, 2010
- Executive Function, Neural Circuitry, and Genetic Mechanisms in SchizophreniaNeuropsychopharmacology, 2009
- A 5′ promoter region SNP in NRG1 is associated with schizophrenia risk and type III isoform expressionMolecular Psychiatry, 2009
- Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complexNature Medicine, 2008
- The Role of Oscillations and Synchrony in Cortical Networks and Their Putative Relevance for the Pathophysiology of SchizophreniaSchizophrenia Bulletin, 2008
- A Neural Coding Scheme Formed by the Combined Function of Gamma and Theta OscillationsSchizophrenia Bulletin, 2008
- Control of Excitatory Synaptic Transmission by C-terminal Src KinasePublished by Elsevier BV ,2008
- Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patientsSchizophrenia Research, 2008
- PSD-95 is a negative regulator of the tyrosine kinase Src in the NMDA receptor complexThe EMBO Journal, 2006
- Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the diseaseProceedings of the National Academy of Sciences of the United States of America, 2006